- This event has passed.
AI/Digital: AI in Healthcare Primary MR – Smoke & Mirrors or a future staple?
June 30 @ 3:00 pm – 3:40 pm
Speakers: Carolyn Chamberlain, Blueprint Partnership and Georgina Butcher, Janssen
Convenor: Letizia Leprini, Bayer Pharma
Unpolluted views, observations, hopes, fears, challenges and opportunities from key Pharma Companies.
Everywhere we look we are bombarded with news about the ‘avalanche of technology’ and the ‘transformational’ impact AI & ML is having across most, if not all, sectors. Carolyn and Georgina will appraise the situation and take a razor-sharp view of AI and ML in Healthcare PMR
How is AI informing and shaping our industry? What are the facts, what are the merits and the dangers? What is the anticipated impact of AI? What intrinsic value will this deliver and when? What and where will be the likely impact and what does this mean for our industry and the skill types we attract? How can we adapt and be at the forefront of this suggested paradigm change?
This session will share findings from interviews with key pharma customers and agencies to establish their views, their perceptions, their concerns – their views on the now Vs the future.
With COVID-19 on everyone’s mind, Carolyn and Georgina will share high level insight from some of the pharma companies and agencies who took part in the initial research, to understand what impact coronavirus might have on the use and adoption of AI/ML in healthcare insights.
There will be an opportunity for discussion at the end of the webinar using the Breakout Rooms function within Zoom – allowing you to interact with colleagues and our speakers.
This is a member only event and is free to attend for members.
With a track record of more than 20+ years of experience in pharmaceutical market research, both client and agency side, working in a variety of roles.
Her career began at AstraZeneca Global where she led insights teams within CV and Oncology for over a decade. Her contributions helped drive the growth of key blockbusters. Carolyn is a well-known strategic market leader in qualitative and quantitative insight in both the UK and overseas. She is passionate about engaging with a diverse range of stakeholders and driving debate in our industry.
Over the last 15 years, she held senior commercial and leadership positions with IPSOS, Kantar Health and the Adelphi Group, whilst also being a key contributor to EphMRA, PMRC and the BHBIA.